4//SEC Filing
Leonard Frank X 4
Accession 0001562180-25-002159
CIK 0001645113other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 4:41 PM ET
Size
7.5 KB
Accession
0001562180-25-002159
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Leonard Frank X
EVP, Pres., Novocure Oncology
Transactions
- Award
Ordinary Shares
2025-03-04$18.19/sh+54,975$999,995→ 198,648 total - Award
Stock Options (Right to buy)
2025-03-04$18.19/sh+81,499$1,482,467→ 81,499 totalExercise: $18.19From: 2026-03-04Exp: 2035-03-03→ Ordinary Shares (81,499 underlying)
Footnotes (2)
- [F1]Represents restricted share units that are scheduled to vest in equal installments on March 4, 2026, 2027 and 2028, subject to the reporting person's continued employment through such dates.
- [F2]Options to buy 81,499 ordinary shares will vest in equal installments on each of March 4, 2026, 2027, 2028 and 2029, subject to the reporting person's continued employment through such dates.
Documents
Issuer
NovoCure Ltd
CIK 0001645113
Entity typeother
Related Parties
1- filerCIK 0001822879
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 4:41 PM ET
- Size
- 7.5 KB